Trump 2020 national press secretary Hogan Gidley says President Trump, briefed by the coronavirus task force, is taking firm steps to bring the United States to recovery.
The United States government reached a $ 1.95 billion agreement with Pfizer and BioNTech for 100 million doses of their experimental COVID-19 vaccine once it has been approved by the Food and Drug Administration.
Under the agreement, an additional 500 million doses can be purchased, and U.S. citizens would receive the vaccine for free.
| Heart | Security | Latest | Change | Change% |
|---|---|---|---|---|
| PFE | PFIZER INC. | 36.69 | +0.19 | + 0.52% |
| BNTX | BIONTECH | 91.60 | +3.40 | + 3.85% |
A Phase 2b / 3 trial of the vaccine, with human subjects, is scheduled to start later this month and will be subject to regulatory review starting in October 2020. If successful, 100 million doses would be manufactured by the end of the month. this year and possibly more than 1.3 billion would be produced in 2021.
“Adding a Pfizer and BioNTech vaccine” to the government’s Operation Warp Speed inoculation development program “increases the chances that we will have a safe and effective vaccine as soon as this year ends,” said Alex Azar, Secretary of Health and Human Services. in a sentence.
Operation Warp Speed aims to deliver 300 million doses of a safe and effective COVID-19 vaccine by January 2021. The initiative accelerates the development, production and distribution of tests, treatments and vaccines for the disease, which has reached pandemic proportions worldwide, infecting more than 3 million people in the United States and killing 142,000.
CLICK HERE TO READ MORE ABOUT FOX BUSINESS
Pfizer and BioNTech are currently evaluating four potential COVID-19 vaccines, two of which have received the Fast Track designation from the FDA, allowing for an accelerated development process.
